SAN DIEGO, CA--(Marketwire - January 11, 2012) -
UT Southwestern Medical Center in Dallas, Texas has acquired and installed a high-resolution PET scanner, the breast application for which is Positron Emission Mammography (PEM). The scanner will be used both for clinical patients as well as for research focused on lowering radiation dose and novel radiotracers. UT Southwestern ranks among the top academic medical centers in the world and was ranked the #1 hospital in Dallas by U.S. News & World Report in 2011.
"Naviscan is thrilled that such a renowned team of radiologists and researchers, including Dr. Phil Evans and Dr. Bob Lenkinski, have chosen to adopt this technology," said Paul J. Mirabella, Chairman and CEO, Naviscan, Inc.
PEM imaging shows the location as well as the metabolic phase of a lesion. This information is critical in determining whether a lesion is malignant and influences the course of treatment by providing an ability to distinguish between benign and malignant lesions, what researchers term "specificity." Recent studies have demonstrated that PEM has similar sensitivity and higher specificity than breast MRI. The scanner is the only FDA-cleared, CE-certified 3D Molecular Breast Imaging (MBI) device on the market with biopsy-guidance.
About Naviscan, Inc.
Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the U.S. and is globally distributed in 34 countries. The Company is headquartered in San Diego, California and is the first to obtain FDA clearance and CE Mark for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance.